Literature DB >> 20945619

Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy.

G Kourtis1, A S Rucco, F Loconte, M F Caiaffa, L Macchia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20945619

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  1 in total

1.  Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases.

Authors:  Irene Fiorino; Filomena Loconte; Anna Simona Rucco; Andrea Nico; Maddalena Vacca; Elisabetta Damiani; Eustachio Nettis; Maria Filomena Caiaffa; Luigi Macchia
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.